GlassScriptPhysician profile
Donna M Mullahy
NPI 1386722783
$3,900.37
in general payments reported to CMS, 2019-2025
39 companies · $1,120 in 2025
The $1,120 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $389 · 2022: $833 · 2023: $612 · 2024: $947 · 2025: $1,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,479 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,478.70 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $589.06 | 2021-2024 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $371.50 | 2021-2025 | Erleada |
| Blue Earth Diagnostics | $303.23 | 2021-2025 | Posluma |
| Sumitomo Pharma America, INC. | $230.70 | 2023-2025 | Gemtesa, Orgovyx |
| Urovant Sciences INC | $212.92 | 2021-2022 | |
| Urogen Pharma, INC. | $204.62 | 2022-2025 | Jelmyto |
| Abbvie INC. | $159.43 | 2022-2025 | |
| Pfizer INC. | $129.77 | 2022-2025 | |
| Procept Biorobotics Corporation | $128.77 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Verity Pharmaceuticals INC. | $125.52 | 2022-2025 | Trelstar |
| Bayer Healthcare Pharmaceuticals INC. | $122.83 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $119.28 | 2021-2025 | Lynparza, Keytruda |
| Srs Medical Systems, INC. | $103.66 | 2023-2024 | Urocuff, Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Dendreon Pharmaceuticals LLC | $99.72 | 2023-2025 | Provenge |
| Olympus America INC. | $93.64 | 2022-2025 | Itind System, Olympus, Soltive |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $82.03 | 2025 | |
| Endo Pharmaceuticals INC. | $65.51 | 2022-2024 | Xiaflex, Aveed |
| Endo USA, INC. | $63.06 | 2024-2025 | Xiaflex |
| Convatec INC. | $59.61 | 2021-2024 | |
| Immunitybio, INC. | $55.91 | 2024-2025 | |
| Myovant Sciences INC. | $51.90 | 2021 | |
| Alnylam Pharmaceuticals INC. | $49.99 | 2023-2024 | Onpattro, Oxlumo |
| Tolmar Pharmaceuticals, INC. | $47.08 | 2021 | |
| Boston Scientific Corporation | $45.98 | 2021-2024 | Rezum Generator |
| Progenics Pharmaceuticals, INC. | $44.47 | 2023-2025 | Pylarify |
| Smith+Nephew, INC. | $38.74 | 2025 | Stravix Pl, Oasis |
| Laborie Medical Technologies Corp. | $37.91 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Sun Pharmaceutical Industries INC. | $36.99 | 2023-2024 | Yonsa |
| Bluewind Medical | $30.77 | 2025 | Revi |
| Dentsply Ih INC. | $29.37 | 2023 | Lofric |
| Coloplast Corp | $25.20 | 2023 | Speedicath |
| Vertex Pharmaceuticals Incorporated | $24.89 | 2025 | |
| Axonics, INC. | $20.12 | 2021 | |
| Clarus Therapeutics INC. | $19.21 | 2021 | |
| Sunovion Pharmaceuticals INC. | $18.81 | 2021 | |
| Antares Pharma, INC. | $16.18 | 2022 | |
| Tolmar, INC. | $15.68 | 2025 | Eligard, Jatenzo |
| Integra Lifesciences Corporation | $14.04 | 2022 | |
| Mission Pharmacal Company | $12.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Mullahy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.